Literature DB >> 11380430

Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome.

D W Jones1, I J MacKie, M J Gallimore, M Winter.   

Abstract

Forty female patients with either primary anti-phospholipid syndrome (n = 26) or systemic lupus erythematosus (anti-phospholipid syndrome positive) (n = 14) were investigated for levels of factor XII, the presence of lupus anticoagulant and antibodies to cardiolipin, beta 2-glycoprotein I and factor XII. Twenty-one patients had a history of recurrent fetal loss (> 2, mean = 2.6). Lupus anticoagulant positivity showed a weak association with recurrent fetal loss (odds ratio = 1.1). While there was no association between the presence of antibodies to cardiolipin or beta 2-glycoprotein I with recurrent fetal loss, antibodies to factor XII showed a strong and statistically significant association (odds ratio = 5.4, P = 0.025).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380430     DOI: 10.1046/j.1365-2141.2001.02776.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.

Authors:  Maria Laura Bertolaccini; Kirti Mepani; Giovanni Sanna; Graham R V Hughes; Munther A Khamashta
Journal:  Ann Rheum Dis       Date:  2006-10-04       Impact factor: 19.103

2.  Recurrent pregnancy loss and thrombophilia.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Giuseppe De Placido
Journal:  J Clin Med Res       Date:  2010-02-26

3.  Acquired factor XII deficiency in a woman with recurrent pregnancy loss: working on a differential diagnosis in a single case.

Authors:  Maristella D'Uva; Ida Strina; Antonio Mollo; Antonio Ranieri; G De Placido; P Di Micco
Journal:  J Transl Med       Date:  2005-12-02       Impact factor: 5.531

4.  Anti-Factor XII Autoantibodies in Patients with Recurrent Pregnancy Loss Recognize the Second Epidermal Growth Factor-Like Domain.

Authors:  Yoshihiro Sato; Toshitaka Sugi; Rie Sakai
Journal:  TH Open       Date:  2019-09-03

5.  Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Antonio Ranieri; Carlo Alviggi; Antonio Mollo; Francesca Fabozzi; Lucia Cacciapuoti; Maria Teresa Scotto di Frega; Mariateresa Iannuzzo; Giuseppe De Placido
Journal:  Biologics       Date:  2008-12

Review 6.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.